• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

Pharmalicensing Ltd
is a division of

News of the day

Industry news search

Recent news

To keep up to date with news from this category use our

Chambliss, Bahner & Stophel Selects Open Text to Manage Documents Firm-Wide
ILTA '08 - Grapevine, TX - 2008-08-26 - Open Text(TM) Corporation (NASDAQ: OTEX, TSX: OTC), a global leader in enterprise content management (ECM), announced today that law firm Chambliss, Bahner & Stophel has selected...

Novus Biologicals is the exclusive USA distributor for Abnova's MaxPab
August 26th, 2008 -- Novus Biologicals is the exclusive USA distributor for Abnova's MaxPab

QLT ANNOUNCES AGREEMENT TO EXCLUSIVELY LICENSE THE ATRIGEL
AUGUST 26, 2008-VANCOUVER, CANADA--QLT Inc. (NASDAQ: QLTI; TSX: QLT) announced today that QLT USA, Inc., its wholly-owned subsidiary, has entered into an exclusive license agreement with Reckitt Benckiser...

Galapagos acquires structure-based drug discovery from Sareum
Mechelen, Belgium and Cambridge, UK; 26 August 2008 - Galapagos NV (Euronext: GLPG) and Sareum Holdings plc (AIM: SAR) announce today that Galapagos has acquired Sareum's assets in drug discovery services, for a total...

Indevus Announces Private Placement of $105 Million of Non-Recourse Notes
LEXINGTON, Mass., August 26, 2008 -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today that it has closed a private placement to institutional investors of $105.0 million of non-recourse notes (the "Notes")....

Law Firm Hunton & Williams Selects Open Text to Manage Conflicts and New Business Intake
ILTA '08 - Grapevine, TX - 2008-08-26 - Open Text(TM) (NASDAQ: OTEX, TSX: OTC), a global leader in enterprise content management (ECM), today announced that global law firm Hunton & Williams LLP will replace its...

HP Completes $13.9 Billion Acquisition of EDS
PALO ALTO, Calif., Aug. 26, 2008 - HP today announced that it has completed its acquisition of Electronic Data Systems Corporation (EDS), creating a leading force in technology services.

Applied Biosystems Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger with Invitrogen Corporation
NORWALK, CT. -- August 25, 2008 - Applied Biosystems Inc. (NYSE: ABI) today announced it has set the date for a special meeting of its shareholders to consider the proposed merger with Invitrogen Corporation. The...

NicOx Provides Update on PF-03187207 and the Ongoing Research Collaboration with Pfizer
SOPHIA ANTIPOLIS, France, August 25, 2008 -NicOx S.A. (Euronext Paris: COX) today announced the results of a dose-ranging phase 2 study conducted with PF-03187207 in Japanese patients with glaucoma by its partner Pfizer...

Biotec Pharmacon to focus on bio-pharmaceutical - sells Immunocorp Animal Health
August 25, 2008--Biotec Pharmacon ASA has reached agreement on the sale of its wholly-owned Immunocorp Animal Health AS subsidiary to Brazil's Biorigin for NOK 37.5 million.

Jerini AG's Management and Supervisory Boards Recommend that Jerini Shareholders Accept Shire Limited's Takeover Offer
Berlin, Germany, August 25, 2008 -Jerini AG (FSE:JI4) announced that its Management and Supervisory Boards have thoroughly examined the offer document published on August 13, 2008 by Shire Deutschland Investments GmbH,...

Invitrogen Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger with Applied Biosystems
CARLSBAD, Calif.-- August 25, 2008--Invitrogen Corporation (NASDAQ:IVGN) today announced it has set the date for a special meeting of its shareholders, to consider the proposed acquisition of Applied Biosystems Inc. The...

Genzyme Corporation and Medicines for Malaria Venture Announce New Collaboration with Advinus Therapeutics to Accelerate Discovery of Novel Therapies for Malaria
August 25, 2008 -- Genzyme Corp. (Nasdaq: GENZ), a global leader in biotechnology, and Medicines for Malaria Venture (MMV), a not-for-profit virtual research and development (R&D) organization dedicated to reducing the...

Codexis, Arch Announce Expanded Collaboration
Redwood City, CA and Mumbai, India - August 25, 2008 Codexis, Inc, a leader in biocatalysis technology, and Arch Pharmalabs Limited, a leading Indian active pharmaceutical ingredients (APIs) and intermediates...

Misonix Announces New Distribution Agreement for the Czech Republic and the Slovak Republic
FARMINGDALE, N.Y -- August 25, 2008--Misonix, Inc. (NASDAQ: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of cancer and worldwide for other acute...

RSV licence assigned to AZ - territories expanded
Melbourne, Australia and Alderly Park, United Kingdom - 22 August 2008 Biota Holdings Limited (ASX:BTA) and AstraZeneca today announced that the 2005 Collaboration and License Agreement with MedImmune has been assigned...

ALPHARMA RESPONDS TO UNSOLICITED PROPOSAL BY KING PHARMACEUTICALS, INC.
Bridgewater, NJ...August 22, 2008...Alpharma, Inc. (NYSE: ALO), a global specialty pharmaceutical company, confirmed that it received this morning an unsolicited, non-binding proposal from King Pharmaceuticals, Inc....

IPEC and UMN Pharma Begin Preparations for Construction of a Manufacturing Facility for UMN-0501, a Pandemic Influenza Vaccine Manufactured using a Novel Cell Culture Technique
August 22, 2008-IHI Plant Engineering Corporation (headquartered in Tokyo, President & CEO: Haruhisa Yamagishi, hereinafter "IPEC"), an affiliate of IHI Corporation and UMN Pharma Inc. (headquartered in Akita, President...

Ash Access Technology Completes AZEPTIC Trial for Zuragen(TM) Injection
AUGUST 22, 2008 7:52 AM EST (Lafayette, Indiana) - - - Ash Access Technology, Inc., a privately held specialty pharmaceutical / medical device company focused on the development and commercialization of proprietary...

King Proposes Acquisition of Alpharma for $33 Per Share in Cash
BRISTOL, TENNESSEE, August 22, 2008 - King Pharmaceuticals, Inc. (NYSE: KG) announced today that it has submitted to the Board of Directors of Alpharma Inc. (NYSE: ALO) a proposal to acquire all of the outstanding...

Bayer And Onyx Begin Enrollment In Storm Trial Studying Nexavar As Adjuvant Therapy For Patients With Liver Cancer
August 21, 2008-Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the companies have begun enrolling patients in the STORM Sorafenib as Adjuvant Treatment in the...

BOEHRINGER INGELHEIM EXTENDS RESEARCH COLLABORATION WITH ABLYNX FOR ALZHEIMER'S DISEASE
GHENT, Belgium , 21 August 2008 Ablynx [Euronext Brussels: ABLX], a pioneer in the discovery and development of Nanobodies

US Defense Logistics Agency announces plans to enter into supply contract to purchase Japanese Encep
Vienna (Austria), August 21, 2008 - Intercell AG (VSE: ICLL) announced that the Defense Logistics Agency (DLA), United States Department of Defense, has posted today a Request for Proposal (RFP) for purchase of Japanese...

Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
OLDSMAR, Fla., Aug. 21, 2008 -- Cryo-Cell International, Inc. and EndGenitor Technologies, Inc. are pleased to announce a new research collaboration to co-develop a combined cellular platform therapeutic for rapidly...

Prevas continues to grow in the area of embedded systems -- signs LOI to acquire company located in Lund
August 21, 2008-Embedded systems are an important component of almost all advanced products in our everyday lives, including cellular phones, home electronics, cars and airplanes. Emfila Software provides software...

Georgian Kidney Expert Embraces GenoMed's Prevention of 90% of Dialysis
ST. LOUIS--August 21, 2008--GenoMed

Mitsubishi Tanabe Pharma completes a majority of shares of Choseido Pharmaceutical Co., Ltd
August 21, 2008 - Mitsubishi Tanabe Pharma announced previously that the company had concluded a basic agreement with Choseido Pharmaceutical Co., Ltd. regarding the acquisition of shares in that company in its...

Fluidigm and Millenium Science Team Up in Australia and New Zealand Distribution Deal
Thursday, August 21, 2008, South San Francisco, CA; Victoria, Australia -Fluidigm Corporation, the inventor of integrated fluidic circuits, has appointed Millennium Science Pty. Ltd. as its exclusive distributor for the...

Fluidigm and Bio-Gene Technology Join Forces in Hong Kong Distribution Deal
Thursday, August 21, 2008, South San Francisco, CA; Hong Kong, People's Republic of China -Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Bio-Gene Technology Ltd. as its...

I-Flow Corporation Announces Award of Multi-year Contract for ON-Q(R) by HealthTrust Purchasing Group
LAKE FOREST, Calif.-- August 21, 2008--I-Flow Corporation (NASDAQ:IFLO) announced today that the company has been awarded a three-year national purchasing contract by HealthTrust Purchasing Group (HealthTrust), a...

Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions and Equipment
LAKE FOREST, Ill., August 21, 2008 -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced new national agreements with Premier Purchasing Partners. The...

BioTime (BTIM.PK)'s Subsidiary, Embryome Sciences, Inc., Licenses Virus-Free iPS and Embryonic Stem Cell Differentiation Technology
ALAMEDA, Calif.--Agust 21, 2008--Embryome Sciences, Inc., a wholly owned subsidiary of BioTime, Inc. (OTCBB:BTIM), announced today the license of a portfolio of patents and patent applications from Advanced Cell...

GENMAB REACHES FIFTH MILESTONE IN OFATUMUMAB COLLABORATION
Copenhagen, Denmark; August 21, 2008 - Genmab A/S (OMX: GEN) announced today it has reached the fifth milestone for ofatumumab (HuMax-CD20

BioGaia enters agreement with Nestl
August 21, 2008--BioGaia's patented probiotic, Lactobacillus reuteri, is already today used in formula products in some European and Asian countries. The new agreement with Nestl

Achievement of milestones for laser analysis technologies
August 21, 2008--Avacta Group plc ("Avacta" or the "Company"), which develops detection and analysis technology aimed at the pharmaceutical, healthcare, security and industrial sectors, announces a pre-close trading...

ALTANA acquires effect pigment business of USBP
Wesel, Germany, August 21, 2008--The specialty chemicals Group ALTANA has signed a contract to acquire the effect pigment business of the American company United States Bronze Powders Inc. (USBP). In 2007, USBP achieved...

MEDINET STARTS COMMERCIALIZATION OF NOVEL CANCER IMMUNOTHERAPY TECHNOLOGY IN JAPAN UTILIZING MAXCYTE'S CELL LOADING SYSTEM
Gaithersburg, MD, USA and Yokohama, Japan - August 20, 2008 - MaxCyte, Inc. and Medinet Co., Ltd. (TSE: #2370) announced today that Medinet will begin commercializing a novel cell engineering approach, utilizing...

Elanco Announces Acquisition of Posilac
GREENFIELD, Ind., Aug 20, 2008 -- Elanco, a division of Eli Lilly and Company (NYSE: LLY), today announced that Lilly has signed an agreement to acquire the worldwide rights to the dairy cow supplement, Posilac

Thermo Fisher Scientific and Sage-N Research Join Forces to Provide a Complete Proteomics Data Analysis Solution
SAN JOSE, Calif. (August 20, 2008) - Thermo Fisher Scientific Inc., the world leader in serving science, and Sage-N Research Inc., the leading supplier of high-throughput proteomics data analysis solutions, today...

Thermo Fisher Scientific and Sage-N Research Join Forces to Provide a Complete Proteomics Data Analysis Solution
SAN JOSE, Calif. (August 20, 2008) -- Thermo Fisher Scientific Inc., the world leader in serving science, and Sage-N Research Inc., the leading supplier of high-throughput proteomics data analysis solutions, today...

Lilly Announces Completion of SGX Acquisition
August 20, 2008-Eli Lilly and Company (NYSE: LLY) today announced that it has completed the acquisition of SGX Pharmaceuticals, Inc. (NASDAQ:SGXP), a San Diego-based biotechnology company focused on drug discovery and...

Partridge Foundation grants $1.25M to Jackson scientist for promising glaucoma research
Bar Harbor, Maine -- August 20, 2008 -- The Partridge Foundation, a John and Polly Guth Charitable Fund, has announced it will make a $1.25 million grant to The Jackson Laboratory to support Professor Simon W.M. John's...

NOVEN SIGNS LICENSE AND SUPPLY AGREEMENTS WITH PROCTER & GAMBLE PHARMACEUTICALS FOR PATCHES TO TREAT HSDD
Miami, FL, August 20, 2008 -- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced that it has entered into global license and supply agreements with Procter & Gamble Pharmaceuticals, Inc. ("P&GP"), a subsidiary...

DIAMYD MEDICAL'S LICENSEE REPORTS PROGRESS WITH GAD IN PARKINSON
Stockholm, August 20, 2008--Neurologix Inc., a biotech company engaged in gene therapy, reports that they have initiated a Phase II study with the GAD-gene within Parkinson's disease. The right to use the GAD-gene has...

Air Products Acquires Harvest Energy Technology to Enhance Global Hydrogen Product Offerings
LEHIGH VALLEY, Pa. (August 20, 2008) - Air Products (NYSE:APD) today announced it has acquired Harvest Energy Technology, Inc., a leader in the development of hydrogen generation technology for industrial and energy...

Lilly Announces Completion of SGX Acquisition
INDIANAPOLIS, Ind., August 20, 2008 -- Eli Lilly and Company (NYSE: LLY) today announced that it has completed the acquisition of SGX Pharmaceuticals, Inc. (Nasdaq: SGXP), a San Diego-based biotechnology company focused...

Eli Lilly and Company to Acquire Monsanto's POSILAC Brand Dairy Product and Related Business
ST. LOUIS, August 20, 2008 -- Monsanto Company (NYSE: MON) announced today that it has entered into an agreement to sell its POSILAC

Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
REHOVOT, Israel and JERSEY CITY, New Jersey, August 20, 2008 -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announced today a collaboration with the National Institute of Health to identify microRNAs involved in the...

Regulus Therapeutics and Collaborators Publish New Data on a Critical Role for miR-21 in Brain Tumors
CAMBRIDGE, Mass. and CARLSBAD, Calif., August 19, 2008 -- Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover,...

Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma
PRINCETON, N.J. & REDWOOD CITY, Calif., August 19, 2008 - Bristol-Myers Squibb Company (NYSE: BMY) and PDL BioPharma, Inc. (NASDAQ: PDLI) today announced an agreement for the global development and commercialization of...

ArunA Biomedical announces exclusive worldwide technology license agreement to commercialize human embryonic stem cell derived mesenchymal cells
Athens, Georgia - - August 19, 2008 ArunA Biomedical, Inc., a leader in human embryonic stem cell derived products, announced today that it has entered into an exclusive worldwide technology licensing agreement with the...

LEO Pharma and iNovacia AB hereby announces the successful completion of their first collaboration
August 19, 2008 -- iNovacia, a Swedish Contract Research Organization, has delivered novel molecules for preclinical development at LEO Pharma. iNovacia will collect a milestone payment due to the successful completion...

AFFITECH AND OMEROS ENTER INTO ANTIBODY DISCOVERY AND DEVELOPMENT AGREEMENT
Seattle, USA and Oslo, Norway- August 19, 2008 - Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, and Affitech AS, a Norwegian human antibody therapeutics company, today announced that they...

MDRNA, Inc. Completes Exclusive License Agreement to RNAi Delivery Peptides
BOTHELL, Wash.-- August 19, 2008--MDRNA, Inc. (Nasdaq: MRNA) announced today that it has signed an exclusive license agreement to intellectual property from the University of Michigan covering cationic peptides for...

CEL-SCI Announces Exclusive Licensing Agreement with Teva for Cancer Drug Multikine
VIENNA, Va., Aug. 19 -- CEL-SCI Corporation (Amex: CVM) announced today that it has entered into an exclusive licensing agreement with Teva Pharmaceutical Industries Ltd. (Teva), a leading global pharmaceutical company,...

Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus
Mumbai, India, August 19, 2008 -- Lupin Ltd., announced today that the Company has entered into a multi-year promotion and marketing agreement for the AeroChamber Plus

AFFITECH AND OMEROS ENTER INTO ANTIBODY DISCOVERY AND DEVELOPMENT AGREEMENT
Seattle, USA and Oslo, Norway- August 19, 2008--Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, and Affitech AS, a Norwegian human antibody therapeutics company, today announced that they...

Pain Therapeutics and King Pharmaceuticals Announce Final Data of Remoxy Phase III Study at World Pain Congress in Scotland
GLASGOW, SCOTLAND - August 19, 2008 - Pain Therapeutics, Inc. (NASDAQ: PTIE) and King Pharmaceuticals, Inc. (NYSE: KG) today presented the final data set of a previously announced pivotal Phase III study of REMOXY

Regulus Therapeutics and Collaborators Publish New Data on a Critical Role for miR-21 in Brain Tumors
CAMBRIDGE, Mass. & CARLSBAD, Calif., Aug 19, 2008 -- Regulus Therapeutics LLC, a joint venture between Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) formed to discover,...

Vion Pharmaceuticals Enters into Agreement with HOVON to Conduct a Phase III Clinical Trial of Cloretazine
NEW HAVEN, CT, August 19, 2008 - VION PHARMACEUTICALS, INC. (PINK SHEETS:VION) announced today that it had entered into an agreement with the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (the "HOVON")...

Karolinska Institutet to Test Vical's Vaxfectin
SAN DIEGO--August 19, 2008--Vical Incorporated (Nasdaq:VICL) today announced a research collaboration with the Karolinska Institutet (KI), a leading European medical university, and the Swedish Institute for Infectious...

TELIK ANNOUNCES DIABETES LICENSE AGREEMENT WITH RECEPTORBIO
Palo Alto, CA - August 19, 2008 - Telik, Inc. (Nasdaq: TELK) announced today that it has entered into a license agreement with ReceptorBio, Inc. which would enable ReceptorBio to develop and commercialize Telik's oral...

Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance to Develop Novel Treatment for Multiple Myeloma
PRINCETON, N.J. & REDWOOD CITY, Calif.--August 19, 2008--Bristol-Myers Squibb Company (NYSE: BMY) and PDL BioPharma, Inc. (NASDAQ: PDLI) today announced an agreement for the global development and commercialization of...

CELLUMEN AND MITSUBISHI TANABE PHARMA CORPORATION COLLABORATE IN DISCOVERY TOXICOLOGY
Pittsburgh, PA, August 19, 2008 --Cellumen, Inc., a discovery toxicology company, today announced an agreement with Mitsubishi Tanabe Pharma Corporation (MTPC), one of the leading pharmaceutical companies in Japan, to...

GE HEALTHCARE IT JOINS WITH ORMED TO DELIVER COMPLETE HOSPITAL INFORMATION SYSTEM
BARRINGTON - AUGUST 18, 2008 - GE Healthcare IT, leading provider of healthcare information technology, today announced a global reseller agreement with Ormed Information Systems. The agreement will allow GE to resell...

Bruker AXS Announces Agreement to Acquire Atomic Force Microscopy (AFM) Company S.I.S. Surface Imaging Systems GmbH
KARLSRUHE & HERZOGENRATH, Germany--Aug. 18, 2008--Bruker AXS GmbH today announced that it has signed an agreement to acquire all of the equity of S.I.S. Surface Imaging Systems GmbH, a company with annual revenues of...

Trimedyne, Inc. (TMED) Enters Into Letter of Intent With FemSuite, LLC
LAKE FOREST, CA-- August 18, 2008 - TRIMEDYNE, INC. (OTCBB: TMED) today announced it has entered into a Letter of Intent with FemSuite, LLC, a privately held company based in San Francisco which develops, manufactures...

ACCESS PHARMACEUTICALS LICENSES MUGARD TO MILESTONE BIOSCIENCES, LLC FOR NORTH AMERICA
DALLAS, TX, August 18, 2008, ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) and Milestone Biosciences, LLC ("Milestone") today announced the signing of a definitive license agreement under which Milestone will market...

Mallinckrodt Baker and Rubicon Research Sign Agreement for Performance Excipient Development
PHILLIPSBURG, N.J., Aug 18, 2008 -- Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its Mallinckrodt Baker business has entered into a licensing and...

CSL Behring Provides $1.2M Grant for World's First Study of Postpartum Women with VWD, Common Bleeding Disorder
King of Prussia, PA -- 18 August 2008--CSL Behring is providing a $1.2 million grant to fund a first-of-its-kind, nationwide study that - when completed - could serve as the basis for determining optimal prophylaxis...

SymBio Pharmaceuticals and Eisai Sign License Agreement for bendamustine hydrochloride (SyB L-0501)
August 18, 2008-SymBio Pharmaceuticals Limited. (Headquarters: Tokyo, President and CEO: Fuminori Yoshida, "SymBio") and Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito, "Eisai") announced today...

Bruker AXS Announces Agreement to Acquire Atomic Force Microscopy (AFM) Company S.I.S. Surface Imaging Systems GmbH
KARLSRUHE & HERZOGENRATH, Germany--Aug. 18, 2008--Bruker AXS GmbH today announced that it has signed an agreement to acquire all of the equity of S.I.S. Surface Imaging Systems GmbH, a company with annual revenues of...

Medline Launches Prevention Campaign and $1 million Grant Program to Support Solutions for Hospital-Acquired Conditions
Monday, August 18, 2008 -- Medline Industries, Inc. announced today a new prevention campaign targeting six hospital-acquired conditions (HACs) and the creation of a $1 million research grant program to support the...

Transition Therapeutics Strengthens Drug Discovery Group
TORONTO, Aug. 18, 2008 - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH, NASDAQ:TTHI) today announced a series of actions to strengthen the Company's drug discovery group. Transition has acquired...

Thermo Fisher Scientific and Toronto's University Health Network Collaborate in Pioneering Biomarker Research
WALTHAM, Mass., Aug 18, 2008 -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a landmark collaboration between its Thermo Fisher Scientific Biomarker Research...

Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers
Orange County, Calif. (August 18, 2008) - Beckman Coulter, Inc. (NYSE:BEC) announced today that it signed an agreement to buy out its U.S. royalty obligation to Nephromics LLC, a Chestnut Hill, Mass.-based company...

SymBio Pharmaceuticals and Eisai Sign License Agreement for bendamustine hydrochloride
August 18, 2008 -- SymBio Pharmaceuticals Limited. (Headquarters: Tokyo, President and CEO: Fuminori Yoshida, "SymBio") and Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito, "Eisai") announced today...

Meda acquires product portfolio from Roche
August 15, 2008 -- Meda has reached an agreement with the Swiss pharma company Roche to acquire four of their well-established pharmaceutical products. The acquired products have strong brand names and the total sales...

Waters and Proteome Software Partner to Integrate Proteomics Technologies
Milford, MA and Portland, OR - August 15, 2008 - Waters Corporation (WAT:NYSE) and Proteome Software, Inc. announced today a collaboration that will provide compatibility between their complementary data acquisition and...

Accelerator Corporation Creates Ninth Biotech Company - Takes Nanogen License to Create Novel Therapeutics
SEATTLE, WA - August 15, 2008 -- Accelerator Corporation, a privately-held biotechnology investment and development company today announced the formation of a new company, Mirina Corporation, focused on developing...

ORGANON PROJECT HALTED BY SCHERING PLOUGH PRIORITISATION - ACRUX CONTINUES CONTRACEPTIVE SPRAY DEVELOPMENT
Melbourne 15 August 2008: Following a portfolio review and re-prioritisation of research and development after its acquisition of Organon, Schering-Plough has today informed Acrux (ASX: ACR) that it will not proceed...

Roche and Meda agree on product transactions
Basel, 15 August 2008 - Roche and Meda, an international specialty pharmaceutical company based in Solna (Stockholm), Sweden, have signed an agreement for the sale of four Roche pharmaceutical products to Meda. The...

Cytos Biotechnology and Pfizer enter into a research, option and license agreement for certain novel vaccines for a defined number of human diseases.
Schlieren (Zurich), Switzerland, August 15, 2008 - Cytos Biotechnology AG (SWX:CYTN) announced today that it has entered into an exclusive global research, option and license agreement with Pfizer Vaccines LLC (Pfizer)...

Ovation Pharmaceuticals Completes In-Licensing Of ATryn
DEERFIELD, Ill., August 14, 2008 - OVATION Pharmaceuticals, Inc. announced today that it has completed its previously announced transaction to obtain the exclusive license for the commercialization and development of...

PAREXEL CLOSES THE ACQUISITION OF CLINPHONE
BOSTON, MA, August 14, 2008 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the successful closing of the acquisition of ClinPhone plc, a...

Eurofins Agroscience Services Inc. acquires Research Options Inc.
August 14 2008 -- Eurofins Agroscience Services Inc., the US operations of Eurofins Agroscience Services, has announced its acquisition of Research Options Inc. The US based CRO now boasts wholly owned field facilities...

PAREXEL CLOSES THE ACQUISITION OF CLINPHONE
BOSTON, MA, August 14, 2008 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the successful closing of the acquisition of ClinPhone plc, a...

GTC BIOTHERAPEUTICS AND OVATION PHARMACEUTICALS CLOSE AGREEMENT TO MARKET AND DEVELOP ATryn
FRAMINGHAM, MA - August 14, 2008 - GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced the closing of its previously announced collaboration agreement with OVATION Pharmaceuticals, Inc. ("OVATION") to develop and...

PAREXEL Closes the Acquisition of ClinPhone
Boston, MA, August 14, 2008 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the successful closing of the acquisition of ClinPhone plc, a...

Symyx Technologies Acquires Integrity Biosolution
Santa Clara, Calif. - August 14, 2008 - Symyx Technologies, Inc. (Nasdaq: SMMX), today announced it has acquired Camarillo, CA-based Integrity Biosolution, LLC in an all-cash transaction. IntegrityBio is a leader in...

Sun Pharma Announces U.S. FTC Clearance for Taro Tender Offer
Mumbai, India: August 14, 2008: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715) today announced that on August 13, 2008, the U.S. Federal Trade Commission (FTC)...

Nanogen Announces Combination with The Elitech Group
SAN DIEGO, CA, and PARIS, FRANCE August 14, 2008 -- Nanogen, Inc. (NASDAQ: NGEN), developer of molecular and rapid in vitro diagnostic products, and The Elitech Group, a private French diagnostics company, announced a...

REG-Avacta Group plc: Product Development Partnership
August 14, 2008--Avacta Group plc ("Avacta"), which develops detection and analysis technology aimed at the pharmaceutical, healthcare, industrial and security sectors, is pleased to announce that it has entered into a...

AstraZeneca and Abbott Expand Relationship to Include Co-Promotion of CRESTOR
August 14, 2008--AstraZeneca and Abbott announced today that they have entered into an agreement for Abbott to promote AstraZeneca's CRESTOR

Immunocorp Animal Health AS secures major research contract
August 14, 2008--Immunocorp Animal Health AS (IAH), a wholly owned subsidiary of Biotec Pharmacon ASA, has been awarded a major research and development contract by the European Commission. The contract will be...

Military Health System to Use McKesson's InterQual Clinical Decision Support for 16th Year
August 14, 2008 -- NEWTON, Mass.-- McKesson announced it won a contract for a full suite of InterQual

Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR
Abbott Park, Illinois and Wilmington, Delaware -August 14, 2008 Abbott (NYSE: ABT) and AstraZeneca (NYSE: AZN) announced today that they have entered into an agreement for Abbott to promote AstraZeneca's CRESTOR

Industry news: Pharmalicensing provides comprehensive industry coverage.

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us